Matregenix, Inc. Market Research Report

Background

Overview

Matregenix, Inc. is a California-based technology company specializing in the design, development, and manufacturing of highly tunable nanofibrous materials. Founded in 2018, the company focuses on creating nanofiber solutions adaptable to a wide range of applications, particularly in the biomedical and filtration sectors. With a commitment to innovation, Matregenix has established itself as a leader in nanofiber technology, offering customizable materials and electrospinning equipment to meet diverse industry needs.

Mission and Vision

Matregenix's mission is to unlock the potential of nanofibers by providing advanced materials and technologies that address complex challenges in various industries. The company's vision is to revolutionize sectors such as healthcare and environmental engineering through the application of nanofiber technology, enhancing product performance and sustainability.

Primary Area of Focus

The company's primary focus areas include:

• Biomedical Applications: Developing nanofiber-based solutions for tissue regeneration, wound healing, and other medical applications.

• Filtration Technologies: Creating advanced filtration media for air and water purification, emphasizing PFAS-free and sustainable materials.

Industry Significance

Matregenix plays a pivotal role in advancing nanofiber technology, contributing to the development of innovative materials that enhance product performance and address environmental concerns. Its work in creating PFAS-free filtration media aligns with global efforts to reduce the environmental impact of hazardous substances.

Key Strategic Focus

Core Objectives

• Innovation in Nanofiber Technology: Continuously advancing nanofiber production methods and applications to meet evolving industry demands.

• Customization and Scalability: Providing tailored nanofiber solutions that can be scaled for various industrial applications.

• Sustainability: Developing environmentally friendly materials, such as PFAS-free filtration media, to promote sustainability.

Specific Areas of Specialization

• Electrospinning Technology: Designing and manufacturing electrospinning equipment for nanofiber production.

• Biomedical Materials: Creating nanofiber-based scaffolds and membranes for medical applications.

• Advanced Filtration Media: Developing high-performance, PFAS-free filtration materials for air and water purification.

Key Technologies Utilized

• Electrospinning: A technique for producing nanofibers with controlled morphology and properties.

• Nanofiber Assembly Lines: Industrial-scale systems for efficient nanofiber production.

• Analytical Tools: Incorporating scanning electron microscopes (SEM) for microstructure characterization.

Primary Markets Targeted

• Healthcare: Medical device manufacturers, tissue engineering, and regenerative medicine sectors.

• Environmental Engineering: Air and water filtration industries seeking sustainable solutions.

Financials and Funding

Funding History

Matregenix has secured multiple funding rounds, primarily through non-dilutive Small Business Innovation Research (SBIR) grants from the National Institutes of Health (NIH) and the U.S. Air Force. These grants have supported the development of various nanofiber-based technologies.

Total Funds Raised

The company has raised a total of approximately $2.04 million through these grants.

Recent Funding Rounds

• August 2025: Awarded a $2.039 million NIH Phase II SBIR grant to advance the MatriNova™ platform for bone regeneration.

• July 2025: Received a $1.25 million DoD Phase II SBIR contract for developing a non-biologic wound-healing matrix for rapid trauma care.

Notable Investors

Investors include the National Institutes of Health and the U.S. Air Force, reflecting confidence in Matregenix's innovative technologies.

Utilization of Capital

The funds are allocated towards:

• Research and Development: Advancing nanofiber technologies and applications.

• Manufacturing Expansion: Enhancing production capabilities to meet growing demand.

• Regulatory Compliance: Ensuring products meet industry standards and regulations.

Pipeline Development

Key Pipeline Candidates

• MatriNova™ Platform: An amino acid-based nanofiber membrane for guided bone regeneration, currently in Phase II development.

• Wound-Healing Matrix: A non-biologic, animal and human-derived tissue-free matrix for rapid trauma care, under development for military and civilian applications.

Stages of Development

• MatriNova™ Platform: Phase II clinical trials for bone regeneration applications.

• Wound-Healing Matrix: Preclinical development, with plans for clinical trials pending further funding.

Target Conditions

• MatriNova™ Platform: Bone regeneration in dental and craniofacial procedures.

• Wound-Healing Matrix: Acute and chronic wounds, including those requiring rapid closure.

Anticipated Milestones

• MatriNova™ Platform: Completion of Phase II trials and preparation for commercialization.

• Wound-Healing Matrix: Initiation of clinical trials following successful preclinical results.

Technological Platform and Innovation

Proprietary Technologies

• TURBO Spinning Technology: An in-house developed electrospinning method for efficient nanofiber production.

Significant Scientific Methods

• Electrospinning: A technique for producing nanofibers with controlled morphology and properties.

• Nanofiber Assembly Lines: Industrial-scale systems for efficient nanofiber production.

• Analytical Tools: Incorporating scanning electron microscopes (SEM) for microstructure characterization.

AI-Driven Capabilities

While specific AI-driven capabilities are not detailed, the company's focus on advanced manufacturing and material science suggests potential integration of AI in process optimization and product development.

Leadership Team

Key Executives

• Dr. Sherif Soliman, Ph.D., MBA: Founder and CEO. A material scientist with over 20 years of experience in biomaterials and nanofibers research.

• Dr. Kevin Guo, Ph.D.: Chief Operating Officer. An R&D scientist specializing in nanotechnologies and microfluidic fabrication.

• Dr. Omar Merhi, Ph.D.: Chief Innovation Officer. Experienced in planning and executing go-to-market strategies and global clinical and regulatory programs for medical devices.

• Ed O’Sullivan, J.D., MBA: Director of Business Development. A seasoned entrepreneur with a robust track record in building, buying, and selling businesses.

• Stephen Bumb: Chief Commercialization Officer. A senior healthcare technologies marketing executive with extensive experience in driving the commercialization of innovative technologies.

Competitor Profile

Market Insights and Dynamics

The nanofiber technology market is experiencing growth due to increasing applications in biomedical and filtration sectors. Advancements in nanofiber production methods and materials are driving innovation and competition.

Competitor Analysis

• Nanomechanics Inc.: A leader in nanomechanics testing systems, with a focus on material characterization.

• TeraPore Technologies: Specializes in nanostructured filtration membranes for water purification.

• OneD Battery Sciences: Develops advanced materials for lithium-ion batteries, including nanofiber-based components.

Strategic Collaborations and Partnerships

• Viamer Biosciences: Exclusive licensing agreement for the development of a dental barrier membrane for guided bone regeneration.

• University of Michigan: Collaboration on the MatriNova™ platform for bone regeneration.

Operational Insights

Matregenix differentiates itself through proprietary nanofiber production technologies,